TARGED BIOPHARMACEUTICALS
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
TARGED BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.targedbiopharmaceuticals.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40.35 M EUR
Technology used in webpage:
Hu-manity.co Cldin
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Onchilles Pharma
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
ZOE Health Study
ZOE Health Study is a biotechnology research company that offers technology to unlock the secrets of the immune system.
Current Employees Featured
Investors List
Hadean Ventures
Hadean Ventures investment in Series A - TargED Biopharmaceuticals
First
First investment in Series A - TargED Biopharmaceuticals
Inkef
Inkef investment in Series A - TargED Biopharmaceuticals
Fund+
Fund+ investment in Series A - TargED Biopharmaceuticals
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - TargED Biopharmaceuticals
Curie Capital
Curie Capital investment in Series A - TargED Biopharmaceuticals
Andera Partners
Andera Partners investment in Series A - TargED Biopharmaceuticals
Utrecht Health Seed Fund
Utrecht Health Seed Fund investment in Series A - TargED Biopharmaceuticals
Curie Capital
Curie Capital investment in Seed Round - TargED Biopharmaceuticals
First
First investment in Seed Round - TargED Biopharmaceuticals
Official Site Inspections
http://www.targedbiopharmaceuticals.com Semrush global rank: 7.86 M Semrush visits lastest month: 685
- Host name: 62.221.215.180
- IP address: 62.221.215.180
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "TargED Biopharmaceuticals"
Home - TargED
Apr 22, 2024 What is TargED? TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.See details»
About Us - TargED
TargED’s lead compound is TGD001. In preclinical models, it has shown effective thrombolysis for various forms of thrombosis. It is currently preclinically validated in two thrombotic indications: Immune Thrombotic Thrombocytopenic Purpura …See details»
TargED Biopharmaceuticals - Crunchbase Company …
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for …See details»
TargED Biopharmaceuticals B.V. - Utrecht, Netherlands - bionity.com
Feb 28, 2022 targedbiopharmaceuticals.com. Contact. Profile News. Contact. About TargED Biopharmaceuticals. TargED Biopharmaceuticals B.V. is a biotechnology company that …See details»
TargED Company Profile 2024: Valuation, Funding
TargED General Information Description. Developer of biopharmaceutical drugs designed to improve the treatment of thrombosis. The company's biological drugs are developed by using small antibodies to deliver enzymes to sites of …See details»
TargED iopharmaceuticals announces the appointment of Erik van …
Organization, between 2015-2021. Over the years, Erik has been involved in the execution of over 20 transactions and partnerships, including a $600M alliance with Pfizer, $290M partnership …See details»
TargED Biopharmaceuticals - LinkedIn
TargED Biopharmaceuticals | 2,542 followers on LinkedIn. Targeted Enzyme Delivery to improve thrombolysis | TargED started in September 2018 and is currently developing one biopharmaceutical ...See details»
TargED Biopharmaceuticals BV: Drug pipelines, Patents, Clinical …
Jul 13, 2023 Explore TargED Biopharmaceuticals BV with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Nervous System Diseases, Hemic and …See details»
TargED Biopharmaceuticals (fka IOVA) - VentureRadar
Mar 2, 2021 "TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED stands for Targeted …See details»
TargED Biopharmaceuticals - Overview, News & Similar
Feb 22, 2022 www.targedbiopharmaceuticals.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Coulter Partners Recruits Chief …See details»
TargED Biopharmaceuticals - Products, Competitors, Financials ...
TargED Biopharmaceuticals is a biotechnology company that operates in the pharmaceutical industry, focusing on the development of first-in-class biological drugs for the treatment of …See details»
TargED Biopharmaceuticals establishes Scientific Advisory Board ...
European Stroke Organization and is a Past President of the World Stroke Organization. His work has been cited more than 200,000 times and his h-index is over 150.See details»
TargED Biopharmaceuticals (fka IOVA) - VentureRadar
Similar Companies: Cereno Scientific Sweden Publicly Traded Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots – to …See details»
TargED Biopharmaceuticals Company Information - Funding, …
Get information on funding, investors, industries, and more for TargED Biopharmaceuticals. See TargED Biopharmaceuticals company profile and funding data.See details»
TargED Biopharmaceuticals raises EUR 39 Million in Series A …
UTRECHT, Netherlands, Feb. 22, 2022 /PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic …See details»
TargED Biopharmaceuticals - Lifesciences @ Work
Over 60% of all cardiovascular patients are believed to suffer from microvascular thrombosis. Existing thrombolytics are not applicable for these patients, as their key target fibrin is missing. …See details»
Team - TargED
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.See details»
TargED Biopharmaceuticals | BioGeneration Ventures
TargED is developing a novel thrombolytic agent that has the potential to treat various thrombotic diseases, including Acute Ischemic Stroke. Year 2020 Field Thrombotic diseases Status ActiveSee details»
TargED Biopharmaceuticals strengthens its Management Team …
Www.targedbiopharmaceuticals.com www.linkedin.com/company/targedbiopharmaceuticals/ TargED Biopharmaceuticals strengthens its Management Team with Key AppointmentsSee details»
NWO Take-Off Phase II grant for the development of Microlyse - a …
We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our …See details»